- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00709176
Outcomes of Triaged Family Care in Advanced Cancer (FOCUS-Triage)
February 10, 2014 updated by: University of Michigan
The purpose of this study is to assess the quality of life of patients with advanced cancer and their family caregivers and to evaluate two doses of a family-based program of care versus control.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The purpose of this study is to:
- determine if family dyads randomly assigned to either a brief or extensive family-based program of care have better proximal and distal outcomes from both a clinical and economic perspective than dyads randomly assigned to usual care
- determine if the brief or extensive program of care has a differential effect on patient and caregiver outcomes depending on the patient's baseline risk for distress status (high versus low).
A longitudinal, randomized clinical trial is being used for patients with advanced lung, colorectal, prostate, and breast cancer and their caregivers.
Study Type
Interventional
Enrollment (Actual)
484
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan Comprehensive Cancer Center
-
Ann Arbor, Michigan, United States, 48106
- St. Joseph Mercy Cancer Center
-
Detroit, Michigan, United States, 48202
- Wayne State University
-
Detroit, Michigan, United States, 48202
- Karmanos Cancer Center
-
Southfield, Michigan, United States, 48075
- Providence Hospital Cancer Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with Stage 3 or 4 breast, prostate, colorectal and lung cancers.
- Patients must be 21 years old or older, physically and mentally able to participate, speak and understand English, have a minimum life expectancy of six months, live within 75 miles of one of the participating sites and have a family caregiver who is willing to participate in the study.
- For this study "family caregiver" is defined as the person who provides the patient with physical and/or emotional support during cancer treatment.
- Family caregivers must be 18 years old or older, physically and mentally able to participate, and speak and understand English.
Exclusion Criteria:
- Patients will be excluded if they have multiple primary cancer sites.
- Family caregivers will be excluded if they, themselves, have been diagnosed with cancer during the previous year and/or are in active treatment for cancer.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Brief
Dyads randomized to BRIEF arm received the Brief FOCUS Program (two home visits and one phone call by a trained nurse) in addition to standard clinical care.
|
Dyads randomized to this arm received the FOCUS Brief Program, two home visits and one phone call by a trained nurse.
Other Names:
|
Experimental: Extensive
Dyads randomized to EXTENSIVE arm received the Extensive FOCUS Program (4 home visits and two phone calls by a trained nurse) in addition to standard clinical care.
|
Dyads randomized to this arm received the FOCUS Extensive Program, 4 home visits and two phone calls by a trained nurse.
Other Names:
|
No Intervention: Control
Dyads randomized to CONTROL arm continued with standard clinical care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in Quality of Life
Time Frame: Baseline, 3 and 6 months
|
Baseline, 3 and 6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Risk for Distress
Time Frame: Baseline
|
Baseline
|
Change in Emotional Distress
Time Frame: Baseline, 3 and 6 months
|
Baseline, 3 and 6 months
|
Change in Appraisal of Illness/Caregiving
Time Frame: Baseline, 3 and 6 months
|
Baseline, 3 and 6 months
|
Change in Uncertainty
Time Frame: Baseline, 3 and 6 months
|
Baseline, 3 and 6 months
|
Change in Hopelessness
Time Frame: Baseline, 3 and 6 months
|
Baseline, 3 and 6 months
|
Change in Self-efficacy
Time Frame: Baseline, 3 and 6 months
|
Baseline, 3 and 6 months
|
Change in Benefits of Illness
Time Frame: Baseline, 3 and 6 months
|
Baseline, 3 and 6 months
|
Change in Family Communication
Time Frame: Baseline, 3 and 6 months
|
Baseline, 3 and 6 months
|
Change in Support
Time Frame: Baseline, 3 and 6 months
|
Baseline, 3 and 6 months
|
Change in Depression
Time Frame: Baseline, 3 and 6 months
|
Baseline, 3 and 6 months
|
Change in Coping
Time Frame: Baseline, 3 and 6 months
|
Baseline, 3 and 6 months
|
Change in Health Care Resource Utilization
Time Frame: Baseline, 3 and 6 months
|
Baseline, 3 and 6 months
|
Change in Caregiver Burden
Time Frame: Baseline, 3 and 6 months
|
Baseline, 3 and 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Laurel L Northouse, PhD, RN, University of Michigan
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Northouse L. Helping families of patients with cancer. Oncol Nurs Forum. 2005 Jul 1;32(4):743-50. doi: 10.1188/05.onf.743-750.
- Northouse LL, Mood DW, Schafenacker A, Kalemkerian G, Zalupski M, LoRusso P, Hayes DF, Hussain M, Ruckdeschel J, Fendrick AM, Trask PC, Ronis DL, Kershaw T. Randomized clinical trial of a brief and extensive dyadic intervention for advanced cancer patients and their family caregivers. Psychooncology. 2013 Mar;22(3):555-63. doi: 10.1002/pon.3036. Epub 2012 Jan 31.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2005
Primary Completion (Actual)
May 1, 2010
Study Completion (Actual)
May 1, 2010
Study Registration Dates
First Submitted
July 1, 2008
First Submitted That Met QC Criteria
July 2, 2008
First Posted (Estimate)
July 3, 2008
Study Record Updates
Last Update Posted (Estimate)
February 11, 2014
Last Update Submitted That Met QC Criteria
February 10, 2014
Last Verified
October 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- R01CA107383 (U.S. NIH Grant/Contract)
- UMCC 2003-094 (Other Identifier: University of Michigan)
- IRBMED No. 2004-0129 (Other Identifier: University of Michigan)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Advanced Cancer
-
STORM Therapeutics LTDRecruitingCancer | Advanced Solid Tumor | Advanced CancerUnited States
-
Merck Sharp & Dohme LLCCompletedAdvanced Cancer Relapsed | Advanced Cancer Refractory
-
Teon Therapeutics, Inc.Merck Sharp & Dohme LLCTerminatedCancer | Advanced Solid Tumor | Advanced Cancer | OncologyUnited States
-
BiOneCure Therapeutics Inc.RecruitingCancer | Advanced Solid Tumor | Advanced Cancer | OncologyUnited States
-
Zhejiang UniversityRecruitingAdvanced Colorectal Cancer | Advanced Hepatocellular Carcinoma | Advanced Gastric Cancer | Advanced Pancreatic CancerChina
-
PfizerTerminatedAdvanced Solid Tumors | Advanced CancerUnited States
-
AVEO Pharmaceuticals, Inc.CompletedAdvanced Cancer | Refractory CancerUnited States
-
Avera McKennan Hospital & University Health CenterCompleted
-
AstraZenecaTerminatedCancer | Advanced Solid Tumors | Advanced Solid MalignanciesUnited States
-
Bristol-Myers SquibbRecruitingAdvanced CancerUnited States, Spain, Belgium, Argentina, Korea, Republic of, Japan
Clinical Trials on Brief FOCUS Program
-
Azienda Ospedaliero-Universitaria CareggiRecruitingDiabetes Mellitus, Type 2Italy
-
Richard CrosbyLouisiana State University Health Sciences Center in New OrleansCompletedHIV Infections | Sexually Transmitted InfectionsUnited States
-
The Hong Kong Polytechnic UniversityCompletedEffects of a Brief Mindful Parenting Program for Hong Kong Chinese Impacted by Social Unrest (MPHKC)Mental Health IssueHong Kong
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Completed
-
Mayo ClinicCompletedTobacco Smoking | Tobacco Use Cessation | Perioperative/Postoperative ComplicationsUnited States
-
The Hong Kong Polytechnic UniversityRecruitingFrailty | Caregiver BurnoutHong Kong
-
University of FloridaNational Institute on Drug Abuse (NIDA)Withdrawn
-
VA Office of Research and DevelopmentNot yet recruiting
-
M.D. Anderson Cancer CenterNational Institutes of Health (NIH); National Human Genome Research Institute...Completed
-
University of ArizonaMariposa Community Health CenterCompleted